Vaxcell Bio (Korea) Price Prediction
| 323990 Stock | KRW 12,810 390.00 2.95% |
Oversold Vs Overbought
31
Oversold | Overbought |
Using Vaxcell Bio hype-based prediction, you can estimate the value of Vaxcell Bio Therapeutics Co from the perspective of Vaxcell Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vaxcell Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Vaxcell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vaxcell Bio after-hype prediction price | KRW 12810.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vaxcell |
Vaxcell Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Vaxcell Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vaxcell Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vaxcell Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vaxcell Bio Estimiated After-Hype Price Volatility
In the context of predicting Vaxcell Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vaxcell Bio's historical news coverage. Vaxcell Bio's after-hype downside and upside margins for the prediction period are 12,808 and 12,812, respectively. We have considered Vaxcell Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vaxcell Bio is very steady at this time. Analysis and calculation of next after-hype price of Vaxcell Bio Therapeu is based on 3 months time horizon.
Vaxcell Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vaxcell Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaxcell Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vaxcell Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 2.19 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
12,810 | 12,810 | 0.00 |
|
Vaxcell Bio Hype Timeline
Vaxcell Bio Therapeu is presently traded for 12,810on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vaxcell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.24%. %. The volatility of related hype on Vaxcell Bio is about 0.0%, with the expected price after the next announcement by competition of 12,810. About 14.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Vaxcell Bio Therapeu had 2:1 split on the 30th of December 2020. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Vaxcell Bio Basic Forecasting Models to cross-verify your projections.Vaxcell Bio Related Hype Analysis
Having access to credible news sources related to Vaxcell Bio's direct competition is more important than ever and may enhance your ability to predict Vaxcell Bio's future price movements. Getting to know how Vaxcell Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vaxcell Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 057050 | Hyundai Home Shopping | 0.00 | 0 per month | 0.00 | (0.19) | 1.82 | (1.87) | 6.00 | |
| 001290 | Sangsangin Investment Securities | 0.00 | 0 per month | 0.00 | (0.21) | 2.00 | (2.32) | 8.73 | |
| 003535 | Hanwha InvestmentSecurities Co | 0.00 | 0 per month | 3.01 | 0.02 | 6.53 | (4.23) | 33.31 | |
| 021080 | Atinum Investment Co | 0.00 | 0 per month | 0.00 | (0.09) | 4.00 | (2.90) | 13.09 | |
| 289080 | SV Investment | 0.00 | 0 per month | 0.00 | (0.32) | 1.98 | (3.71) | 12.35 | |
| 118000 | Chorokbaem Healthcare Co | 0.00 | 0 per month | 0.00 | (0.37) | 1.69 | (2.49) | 8.63 | |
| 078020 | EBEST Investment Securities | 0.00 | 0 per month | 0.00 | (0.36) | 1.84 | (2.54) | 7.02 |
Vaxcell Bio Additional Predictive Modules
Most predictive techniques to examine Vaxcell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vaxcell using various technical indicators. When you analyze Vaxcell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vaxcell Bio Predictive Indicators
The successful prediction of Vaxcell Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vaxcell Bio Therapeutics Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vaxcell Bio based on analysis of Vaxcell Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vaxcell Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vaxcell Bio's related companies.
Story Coverage note for Vaxcell Bio
The number of cover stories for Vaxcell Bio depends on current market conditions and Vaxcell Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vaxcell Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vaxcell Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Vaxcell Bio Short Properties
Vaxcell Bio's future price predictability will typically decrease when Vaxcell Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vaxcell Bio Therapeutics Co often depends not only on the future outlook of the potential Vaxcell Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaxcell Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.2 M | |
| Cash And Short Term Investments | 27.3 B | |
| Shares Float | 9 M |
Complementary Tools for Vaxcell Stock analysis
When running Vaxcell Bio's price analysis, check to measure Vaxcell Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcell Bio is operating at the current time. Most of Vaxcell Bio's value examination focuses on studying past and present price action to predict the probability of Vaxcell Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcell Bio's price. Additionally, you may evaluate how the addition of Vaxcell Bio to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |